To establish the tumor-promoting effect of endogenous IRF5 on thyroid cancer cells, we silenced its expression using the doxycicline inducible pTRIPZ vector (shRNA anti-IRF5, gene ID NM_001098627, Open Biosystems). The gene discussed is IRF5; the disease is neoplasm.